Restasis and Vancomycin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Restasis (cyclosporine) and Vancomycin (vancomycin). Common drug interactions include streptococcal bacteraemia among females and osteopenia among males.
The phase IV clinical study analyzes what interactions people have when they take Restasis and Vancomycin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.
What is Vancomycin?
Vancomycin has active ingredients of vancomycin. eHealthMe is studying from 17,165 Vancomycin users. Check the latest studies of Vancomycin.
23 people who take Restasis and Vancomycin together, and have interactions are studied.

What are the common drug interactions of Restasis and Vancomycin, by gender? *:
female:
- Streptococcal bacteraemia (a bacterial infection of blood)
- Catheter site swelling
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Device related infection
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Implant site infection
- Infusion site reaction
- Infusion site vesicles (fluid- or air-filled cavity or sac at infusion site)
- Nausea (feeling of having an urge to vomit)
male:
- Osteopenia (a condition where bone mineral density is lower than normal)
- Chronic kidney disease
- Multiple fractures
- Osteonecrosis (death of bone)
- Spinal fracture (fracture in one of vertebrae)
- Tooth injury
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Ankle fracture
- Anxiety
- Bone loss
What are the common drug interactions of Restasis and Vancomycin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Ankle fracture
- Anxiety
- Bone density decreased
- Bone loss
- Emotional distress
- Gallbladder disorder
- Ligament rupture (tear in ligament)
- Lower limb fracture
40-49:
- Chronic kidney disease
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
50-59:
- Catheter site swelling
- Chills (felling of cold)
- Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
- Device related infection
- Fatigue (feeling of tiredness)
- Headache (pain in head)
- Implant site infection
- Infusion related reaction
- Infusion site reaction
- Infusion site vesicles (fluid- or air-filled cavity or sac at infusion site)
60+:
- Streptococcal bacteraemia (a bacterial infection of blood)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Insomnia (sleeplessness)
- Multiple fractures
- Osteomyelitis (infection of bone)
- Osteonecrosis (death of bone)
- Spinal fracture (fracture in one of vertebrae)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Tooth injury
- Tooth loss
What are the existing conditions these people have? *
- Skin Infection: 8 people, 34.78%
- Device Related Infection: 8 people, 34.78%
- Immunodeficiency Common Variable: 8 people, 34.78%
- Headache (pain in head): 8 people, 34.78%
- Primary Immunodeficiency Syndrome: 7 people, 30.43%
- Hiv Infection: 5 people, 21.74%
- Depression: 4 people, 17.39%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 17.39%
- Immune System Disorder: 3 people, 13.04%
- High Blood Pressure: 3 people, 13.04%
* Approximation only. Some reports may have incomplete information.
Do you take Restasis and Vancomycin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Restasis (35,199 reports)
- Vancomycin (17,165 reports)
Browse all drug interactions of Restasis and Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Vancomycin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Restasis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vancomycin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on cyclosporine and vancomycin (the active ingredients of Restasis and Vancomycin, respectively), and Restasis and Vancomycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Definity cause Hot Flush? - a second ago
- Drug interactions of Revlimid and Antivert - 4 seconds ago
- Drug interactions of Zyrtec and Dofetilide - 5 seconds ago
- Drug interactions of Tigan and Savella - 8 seconds ago
- Could Lonsurf cause Abdominal Discomfort? - 23 seconds ago
- Drug interactions of Zymar and Brimonidine - 24 seconds ago
- Could Methylprednisolone cause Systemic Sclerosis (Scleroderma)? - 25 seconds ago
- Could Roxicodone cause Gastritis? - 27 seconds ago
- Could Antivert cause Dry Skin? - 31 seconds ago
- Could Sabril cause Constipation? - 38 seconds ago